ロード中...
RAF/MEK dependence of KRAS mutant pancreatic ductal adenocarcinomas
Studies employing genetically engineered mouse models indicate that RAF activation is sufficient to induce pancreas intraepithelial neoplasms (PanINs) suggesting that MEK inhibitor-based combination approaches may have clinical utility in patients with pancreatic ductal adenocarcinomas.
保存先:
| 出版年: | Cancer Discov |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031078/ https://ncbi.nlm.nih.gov/pubmed/22886659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0308 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|